Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Evidence for Evolution02:55

The Evidence for Evolution

48.0K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.0K
Convergent Evolution01:54

Convergent Evolution

32.8K
Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
32.8K
Eukaryotic Evolution01:24

Eukaryotic Evolution

40.9K
The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
40.9K
Synteny and Evolution02:31

Synteny and Evolution

3.8K
John H. Renwick first coined the term “synteny” in 1971, which refers to the genes present on the same chromosomes, even if they are not genetically linked. The species with common ancestry tend to show conserved syntenic regions. Therefore, the concept of synteny is nowadays used to describe the evolutionary relationship between species.
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
3.8K
Gene Evolution - Fast or Slow?02:05

Gene Evolution - Fast or Slow?

3.7K
3.7K
Gene Evolution - Fast or Slow?02:05

Gene Evolution - Fast or Slow?

8.2K
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midterm results of iCover stent grafts as bridging stent in fenestrated endovascular aortic repair.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Endovascular Management of the Sutton-Kadir Syndrome: A Case Report.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

Long Term Follow Up of Bridging Stents is Necessary!

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Consensus-Driven Vessel Preparation and Definitive Endovascular Treatment Strategies for Femoropopliteal Arterial Lesions Based on Plaque Morphology.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.

The Journal of cardiovascular surgery·2025
Same author

Dynetic-35 cobalt chromium balloon-expandable stent for iliac lesions: 12-month results of the BIONETIC-I multi-center study.

CVIR endovascular·2025
Same journal

Pelvic venous disease and lymphatic dysfunction: evaluating the evidence for a proposed continuum.

The Journal of cardiovascular surgery·2026
Same journal

Incidence of post-dissection aneurysmal formation and need for secondary intervention after surgery for acute type A aortic dissections: a systematic review and meta-analysis of observational studies.

The Journal of cardiovascular surgery·2026
Same journal

The expertise effect: how advancing skills in frozen elephant trunk have broadened surgical indication for acute dissection.

The Journal of cardiovascular surgery·2026
Same journal

Outcomes of pulmonary embolism response teams: a systematic review.

The Journal of cardiovascular surgery·2026
Same journal

Use of large bore devices in the treatment of pulmonary embolism.

The Journal of cardiovascular surgery·2026
Same journal

Contemporary role of systemic thrombolysis in the management of acute pulmonary embolism.

The Journal of cardiovascular surgery·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Daily Transfers, Archiving Populations, and Measuring Fitness in the Long-Term Evolution Experiment with Escherichia coli
15:00

Daily Transfers, Archiving Populations, and Measuring Fitness in the Long-Term Evolution Experiment with Escherichia coli

Published on: August 18, 2023

4.3K

EVOLUTION Study: 12-month results.

Marc Bosiers1, Koen Deloose2, Joren Callaert2

  • 1AZ St-Blasius Hospital, Dendermonde, Belgium - marc.bosiers@telenet.be.

The Journal of Cardiovascular Surgery
|January 31, 2019
PubMed
Summary
This summary is machine-generated.

The EVOLUTION study found that the iVolution stent achieved an 86.3% primary patency rate at 12 months for femoropopliteal lesions. This demonstrates the effectiveness of nitinol stents in treating these vascular conditions.

More Related Videos

Molecular Evolution of the Tre Recombinase
12:02

Molecular Evolution of the Tre Recombinase

Published on: May 29, 2008

10.1K
Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat
06:03

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat

Published on: September 20, 2016

15.2K

Related Experiment Videos

Last Updated: Jan 30, 2026

Daily Transfers, Archiving Populations, and Measuring Fitness in the Long-Term Evolution Experiment with Escherichia coli
15:00

Daily Transfers, Archiving Populations, and Measuring Fitness in the Long-Term Evolution Experiment with Escherichia coli

Published on: August 18, 2023

4.3K
Molecular Evolution of the Tre Recombinase
12:02

Molecular Evolution of the Tre Recombinase

Published on: May 29, 2008

10.1K
Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat
06:03

Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat

Published on: September 20, 2016

15.2K

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • The EVOLUTION study investigated the iVolution stent in a prospective, non-randomized setting.
  • The study focused on patients with TASC A&B femoropopliteal lesions.
  • 12-month follow-up data for the total cohort are reported.

Purpose of the Study:

  • To evaluate the primary patency of the iVolution stent at 12 months.
  • To assess Target Lesion Revascularization (TLR) rates within 12 months.
  • To determine the efficacy of nitinol stents in femoropopliteal interventions.

Main Methods:

  • 120 patients with TASC A&B femoropopliteal lesions were enrolled between April 2015 and November 2016.
  • The mean lesion length was 89.63 mm, with 60% being stenotic lesions.
  • Primary patency was defined by duplex ultrasound criteria and absence of TLR.

Main Results:

  • The primary patency rate was 86.30% at 12-month follow-up.
  • Freedom from Target Lesion Revascularization (TLR) was 88.00% at 12 months.
  • These results support the use of bare metal nitinol stents.

Conclusions:

  • Bare metal self-expandable nitinol stents are effective for TASC A&B femoropopliteal lesions.
  • Further research with longer follow-up is warranted.
  • Comparison with drug-eluting technologies should be explored.